MedTrace Logo

Supplementation Trial on Arginine With Metabolic Profiling

NCT03409380 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-09-14

No results posted yet for this study

Summary

This study will assess effects of an acute dose of the amino acid arginine on metabolism in healthy young men.

Conditions

  • Protein
  • Amino Acid
  • Arginine

Interventions

DIETARY_SUPPLEMENT

Arginine Drink

10 g of arginine in a formulated drink

DIETARY_SUPPLEMENT

Plain Drink

formulated drink

Sponsors & Collaborators

  • Jennifer C. Rood

    collaborator UNKNOWN

  • Robbie A. Beyl

    collaborator UNKNOWN

  • Martin, Corby, K., M.D.

    collaborator INDIV

  • Frank L. Greenway

    collaborator UNKNOWN

  • Pennington Biomedical Research Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-08
Primary Completion
2019-07-08
Completion
2019-07-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03409380 on ClinicalTrials.gov